DCF — SINGING RIVER HEALTH SYSTEM
Enterprise Value: $-822.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-822.1M
Enterprise Value
$-257.2M
PV of Cash Flows
$-564.9M
PV of Terminal Value
$-909.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $428.4M | $-52.8M | -12.0% | $-70.9M | $-64.5M |
| Year 2 | $441.2M | $-50.0M | -11.0% | $-68.6M | $-56.7M |
| Year 3 | $454.5M | $-46.9M | -10.0% | $-66.2M | $-49.7M |
| Year 4 | $468.1M | $-46.0M | -10.0% | $-65.8M | $-44.9M |
| Year 5 | $482.1M | $-46.2M | -10.0% | $-66.6M | $-41.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-822.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$415.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.12823352999263893
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5